PAG
RPRX icon

Private Advisor Group’s Royalty Pharma RPRX Stock Holding History

Private Advisor Group’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$492K Buy
10,251
+42
+0.4% +$1.84K ﹤0.01% 1865
2025
Q4 		$394K Buy
10,209
+3,080
+43% +$117K ﹤0.01% 1976
2025
Q3 		$252K Buy
+7,129
New +$258K ﹤0.01% 2193
2020
Q3 		– Sell
-550
Closed -$27K – 3052
2020
Q2 		$27K Buy
+550
New +$27.2K ﹤0.01% 2416

Other funds holding RPRX

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Private Advisor Group's RPRX Position: Q1 2026 in Review

Private Advisor Group increased its Royalty Pharma (RPRX) stake by 0.41% in Q1 2026, buying an estimated $1.84K and bringing the position to 10,251 shares worth $492K. The position accounts for ﹤0.01% of the portfolio, ranked #1865.

Private Advisor Group first reported a position in RPRX in Q2 2020 and has held it in 4 quarters since. 587 funds tracked by Wall St. Rank hold RPRX as of Q1 2026.

  • Private Advisor Group held 10,251 shares of Royalty Pharma worth $492K as of Q1 2026.
  • Private Advisor Group bought 42 Royalty Pharma shares in Q1 2026, an estimated $1.84K.
  • Royalty Pharma made up ﹤0.01% of Private Advisor Group's portfolio in Q1 2026, its #1865 holding.
  • Private Advisor Group first reported a position in Royalty Pharma in Q2 2020 and has held it in 4 quarters since.
  • 587 funds tracked by Wall St. Rank held Royalty Pharma as of Q1 2026.

Based on Private Advisor Group's 13F filing for Q1 2026, filed 27 Apr 2026.